TSC2 and tuberous sclerosis: De novo pathogenic variants constitute approximately 80% of TSC cases, being approximately four times more common in TSC2 than in TSC1. In familial cases, there is no difference between the prevalence of pathogenic variants in TSC1 and TSC210,13.